Skip to main content

Microbiome and Cancer

Call for papers: Microbiome and Cancer

Edited by:   Christopher Staley, University of Minnesota, USA (BMC Microbiology) 
                   Jacques Ravel, University of Maryland, USA (Microbiome)
                   Sean Devlin, Memorial Sloan-Kettering Cancer Center, USA (BMC Cancer)

New Content Item

BMC CancerBMC Microbiology and Microbiome invite submissions to the ‘Microbiome and Cancer’ collection.

With microbiome research moving from a predominantly data-driven field towards understanding its contribution at a more mechanistic level, the impact of the microbiome on health and human disease has surfaced. At the same time, cancer research has diversified its approach with increasing emphasis for a multifaceted treatment model to ensure effective treatment towards a cure. As the intersection of the two fields, the role of the microbiome in cancer disease predisposition, risk, initiation, progression, diagnosis, prognosis and treatment is becoming increasingly apparent and a new focus of research. In recognition of this important and growing field of research, we hereby welcome submissions on ‘Microbiome and cancer’ aiming to present a collection of primary research articles and reviews on the topic. 

We invite submissions from all aspects of this developing field including but not limited to: 

  • reports on the cancer microbiome, 
  • effect of the microbiome on cancer initiation, tumorigenesis and progression
  • microbiome-driven increased cancer risk or predisposition 
  • the evolving role of microbiome modulation products
  • microbiome-driven changes in the metabolic and physiologic states in the tumor microenvironment,
  • biology of cancers triggered by microbiome-driven immune modulations
  • metabolomics and metagenomic studies at the interface of microbiome and cancer
  • the microbiome as a diagnostic/prognostic indicator for cancer
  • the effect of gut and tissue microbiomes on cancer therapy
  • the role of the cancer microbiome in therapy resistance

The collection is now open for submissions until 30th September 2021.

Working together: We would like to ensure your manuscript is placed in the most appropriate journal within this collection and, for this reason, the Editors may suggest your manuscript be transferred to another journal within the collection for review. Each manuscript will undergo peer review as normal in the appropriate journal and be included in this collection upon publication.

To submit to BMC Cancer please click here. See our journal submission guidelines.
To submit to BMC Microbiology please click here. See our journal submission guidelines.
To submit to Microbiome please click here. See our journal submission guidelines.

For pre-submission enquiries for the collection contact Linda Gummlich (for BMC Cancer), Akila Sridhar (for BMC Microbiology) or Srimathy Sriskantharajah (for Microbiome)

Our Guest Editors:

Christopher Staley

New Content ItemThe intestinal microbiota is a vital organ critical to the development, functioning, and health of the human the host. The Staley Lab at University of Minnesota research focus is to characterize how disruptions in this community affect the onset and progression of diseases and conditions e.g., obesity, colorectal cancer, and inflammatory bowel diseases. By applying microbial ecology principles and leveraging next-generation sequencing technologies, their goal is to develop targeted, microbiota-based therapies to improve patient outcomes. Chris is a Senior Board Member for BMC Microbiology.

Sean Devlin

New Content ItemSean Devlin is a Assistant Professor in Biostatistics as Memorial Sloan Kettering Cancer Centre. His research interests are in the development of adaptive and nonparametric regression methods for cancer research. He was involved in developing a novel algorithm to refine and improve the discriminatory ability of an existing prognostic classifier by incorporating new genomic markers for censored survival data. His current research interests also include developing risk scores for high dimensional survival data when multiple markers may predict treatment response. Sean is a Senior Board Member for BMC Cancer

Collection articles:

  1. The gut microbiota influences many aspects of host physiology, including immune regulation, and is predictive of outcomes in cancer patients. However, whether conventional myelosuppressive chemotherapy affects...

    Authors: Lito E. Papanicolas, Sarah K. Sims, Steven L. Taylor, Sophie J. Miller, Christos S. Karapetis, Steve L. Wesselingh, David L. Gordon and Geraint B. Rogers

    Citation: BMC Cancer 2021 21:591

    Content type: Research article

    Published on:

  2. Emerging evidence implicates the gut microbiome in liver inflammation and hepatocellular carcinoma (HCC) development. We aimed to characterize the temporal evolution of gut dysbiosis, in relation to the phenot...

    Authors: J. Behary, A. E. Raposo, N. M. L. Amorim, H. Zheng, L. Gong, E. McGovern, J. Chen, K. Liu, J. Beretov, C. Theocharous, M. T. Jackson, J. Seet-Lee, G. W. McCaughan, E. M. El-Omar and A. Zekry

    Citation: BMC Microbiology 2021 21:113

    Content type: Research article

    Published on:

  3. Triazole, polyene, and echinocandin antifungal agents are extensively used to treat invasive fungal infections (IFIs); however, the optimal prophylaxis option is not clear. This study aimed to determine the op...

    Authors: Huilan Zeng, Zhuman Wu, Bing Yu, Bo Wang, Chengnian Wu, Jie Wu, Jing Lai, Xiaoyan Gao and Jie Chen

    Citation: BMC Cancer 2021 21:404

    Content type: Research article

    Published on:

  4. Composition and maintenance of the microbiome is vital to gut homeostasis. However, there is limited knowledge regarding the impact of high doses of radiation, which can occur as a result of cancer radiation t...

    Authors: Raj Kalkeri, Kevin Walters, William Van Der Pol, Braden C. McFarland, Nathan Fisher, Fusataka Koide, Casey D. Morrow and Vijay K. Singh

    Citation: BMC Microbiology 2021 21:93

    Content type: Research article

    Published on:

  5. Increase in the number of infections caused by Gram-negative bacteria in neutropenic cancer patients has prompted the search for novel therapeutic agents having dual anticancer and antimicrobial properties. Ba...

    Authors: Preeti Sharma, Sumanpreet Kaur, Bhupinder Singh Chadha, Raminderjit Kaur, Manpreet Kaur and Sukhraj Kaur

    Citation: BMC Microbiology 2021 21:39

    Content type: Research article

    Published on:

  6. Alteration in gut microbiota has been recently linked with childhood leukemia and the use of chemotherapy. Whether the perturbed microbiota community is restored after disease remission and cessation of cancer...

    Authors: Ling Ling Chua, Reena Rajasuriar, Yvonne Ai Lian Lim, Yin Ling Woo, P’ng Loke and Hany Ariffin

    Citation: BMC Cancer 2020 20:151

    Content type: Research article

    Published on:

  7. The gut microbiota is an important modulator of immune, metabolic, psychological and cognitive mechanisms. Chemotherapy adversely affects the gut microbiota, inducing acute dysbiosis, and alters physiological ...

    Authors: Julie M. Deleemans, Faye Chleilat, Raylene A. Reimer, Jan-Willem Henning, Mohamad Baydoun, Katherine-Ann Piedalue, Andrew McLennan and Linda E. Carlson

    Citation: BMC Cancer 2019 19:1243

    Content type: Study protocol

    Published on:

  8. Mouse and human studies support the promise of dry beans to improve metabolic health and to lower cancer risk. In overweight/obese patients with a history of colorectal polyps or cancer, the Beans to Enrich th...

    Authors: Xiaotao Zhang, Gladys Browman, Wesley Siu, Karen M. Basen-Engquist, Samir M. Hanash, Kristi L. Hoffman, Pablo C. Okhuysen, Paul Scheet, Joseph F. Petrosino, Scott Kopetz and Carrie R. Daniel

    Citation: BMC Cancer 2019 19:1233

    Content type: Study protocol

    Published on:

  9. Breast cancer ranks first in women, and is the second cause of death in this gender. In addition to genetics, the environment contributes to the development of the disease, although the factors involved are no...

    Authors: Julio Plaza-Díaz, Ana I. Álvarez-Mercado, Carmen M Ruiz-Marín, Iris Reina-Pérez, Alejandro J. Pérez-Alonso, María Belén Sánchez-Andujar, Pablo Torné, Tania Gallart-Aragón, María Teresa Sánchez-Barrón, Saturnino Reyes Lartategui, Federico García, Natalia Chueca, Ana Moreno-Delgado, Katia Torres-Martínez, María José Sáez-Lara, Cándido Robles-Sánchez…

    Citation: BMC Cancer 2019 19:495

    Content type: Study protocol

    Published on:

  10. A causal association has been suggested between certain bacteria and colorectal cancer (CRC). Only a few studies have, however, investigated the presence of these bacteria directly in colon tissue with conflic...

    Authors: Caspar Bundgaard-Nielsen, Ulrik T. Baandrup, Lars P. Nielsen and Suzette Sørensen

    Citation: BMC Cancer 2019 19:399

    Content type: Research article

    Published on: